Aehr Test Systems price to free cash flow AEHR
Market value divided by free cash flow over the last twelve months, since 2014.
- Today, Oct 23, 2026
- n/m
- not a meaningful number
- Last meaningful
- 461×
- Oct 2024
- 8-year median
- 118×
- 8-year range
- 28.2× to 475×
- Peer median
- 18.6×
Aehr Test Systems' price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.
It was last meaningful in Oct 2024, at 461×.
On the days it had one over the last 8 years, its median was 118×, from 28.2× in Dec 2018 to 475× in Jul 2023.
Price to free cash flow over time
The dashed line is the 8-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2024 | 461× | 51.1× | 461× |
| 2023 | 111× | 101× | 475× |
| 2022 | 119× | 54.0× | 430× |
| 2021 | n/m a value too high to mean anything | ||
| 2020 | n/m a value too high to mean anything | ||
| 2019 | 29.2× | 29.2× | 29.6× |
| 2018 | 29.6× | 28.2× | 41.9× |
| 2017 | n/m a value too high to mean anything | ||
| 2016 | n/m a value too high to mean anything | ||
| 2015 | n/m a value too high to mean anything | ||
| 2014 | 25.3× | 21.5× | 27.2× |
Against its peers
Companies in Hardware, Equipment & Parts nearest Aehr Test Systems' size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| AEHRAehr Test Systems | n/m |
| CTSCTS | 16.6× |
| ALNTAllient | 54.2× |
| BHEBenchmark Electronics | 18.6× |
| ITRIItron | 10.0× |
| OLEDUniversal Display | 18.2× |
| BDCBelden | 19.2× |
| VSHVishay Intertechnology | n/m |
| VREXVarex Imaging | n/m |
| TRNSTranscat | 30.2× |
| FEIMFrequency Electronics | n/m |
| Peer median | 18.6× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Aehr Test Systems
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.